Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Federal Trade Commission
Farmers Insurance
McKinsey
UBS
Moodys
Fuji
Chinese Patent Office

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050314

« Back to Dashboard

NDA 050314 describes FUNGIZONE, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs. Additional details are available on the FUNGIZONE profile page.

The generic ingredient in FUNGIZONE is amphotericin b. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 050314
Tradename:FUNGIZONE
Applicant:Apothecon
Ingredient:amphotericin b
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050314

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength3%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Fuji
Baxter
Accenture
AstraZeneca
Johnson and Johnson
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.